This peptide is a dual agonist, activating both the GLP-1 and GIP receptors, two hormones involved in appetite control, insulin secretion, and blood sugar regulation
Though they were originally approved as a treatment for diabetes, it soon became clear that their ability to help people lose weight even people whod been unsuccessful with other weight loss treatments bordered on the miraculous
The review found that telehealth could improve access to menopause care, although the authors said it was not a universal solution
Is GLP-1 the same as Semaglutide GLP-1
YOUR JOURNEY TO OPTIMAL HEALTH, WELLNESS AND BEAUTY begins here
This dual receptor action allows Tirzepatide to enhance insulin secretion, suppress glucagon release, slow digestion, and boost satiety similarly to semaglutide, but with the added benefit of activating the GIP receptor